Italia markets open in 54 minutes
Dow Jones
39.308,00 -23,90 (-0,06%) Nasdaq
18.188,30 +159,54 (+0,88%) Nikkei 225
40.825,56 -88,09 (-0,22%) EUR/USD
1,0826 +0,0012 (+0,11%) Bitcoin EUR
50.441,74 -3.924,59 (-7,22%) CMC Crypto 200
1.137,13 -71,56 (-5,93%)
TEVA Jan 2025 30.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 12:06PM EDT. Mercato aperto.
| Chiusura precedente | 0,0800 |
| Aperto | 0,0700 |
| Denaro | 0,0000 |
| Domanda | 0,0000 |
| Prezzo d'esercizio | 30,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 0,0700 - 0,0800 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | N/D |
GlobeNewswireTeva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.
© 2024 Yahoo. Tutti i diritti riservati.